Why your #pharma #serialisation RFI should not be like Forrest Gump’s box of chocolates –

Posted On Jun 13 2017 by

#forrest pharma # Why your #pharma #serialisation RFI should not be like Forrest Gump’s box of chocolates – full of surprises! Published March 1, 2016 As Forrest Gump s Momma could have said, An RFI is like box of chocolates you never know what s inside. Photo courtesy of Loren Javier Now that the EU-FMD clock has started ticking, pharma companies are compelled to take action. The first step for those in the pharma industry is often to generate a RFI for their serialization/traceability system. This is completely understandable when faced with the need to create a new and unfamiliar …


MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm – CenterWatch News

Posted On May 3 2017 by

#mds pharma services #


Why your #pharma #serialisation RFI should not be like Forrest Gump’s box of chocolates –

Posted On Apr 19 2017 by

#forrest pharma # Why your #pharma #serialisation RFI should not be like Forrest Gump’s box of chocolates – full of surprises! Published March 1, 2016 As Forrest Gump s Momma could have said, An RFI is like box of chocolates you never know what s inside. Photo courtesy of Loren Javier Now that the EU-FMD clock has started ticking, pharma companies are compelled to take action. The first step for those in the pharma industry is often to generate a RFI for their serialization/traceability system. This is completely understandable when faced with the need to create a new and unfamiliar …


To be niche players in neurology oncology: Eisai Pharma #laureate #pharma

Posted On Apr 19 2017 by

#eisai pharma # While most Japanese drugmakers have been cautious post the Daiichi Sankyo’s crisis in Ranbaxy, Eisai Pharma is the only Japanese pharma company that continues to place its bet on the Indian pharma space. The company has consolidated its manufacturing and commercial operations in India and is adopting a multipronged growth strategy. The company which has been operating a Greenfield manufacturing facility in Vizag and is looking to grow its business in India. The plant currently caters entirely to the Japanese market. However Eisai wants to convert its India facility into a global sourcing hub that will export …


MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm – CenterWatch News

Posted On Apr 14 2017 by

#mds pharma services #


MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm – CenterWatch News

Posted On Apr 6 2017 by

#mds pharma services #


Global pharmaceutical industry is in a strategic crisis – Business models must be adjusted #sinclair

Posted On Apr 5 2017 by

#global pharmaceutical industry # Munich, January 06, 2013 Global pharmaceutical industry is in a strategic crisis – Business models must be adjusted Three out of four pharmaceutical companies are convinced their industry is in the midst of a strategic crisis Price and cost pressure, regulatory changes and expiring patents are leading to shrinking margins Emerging markets offer the biggest growth opportunities for the pharmaceutical industry – Their market share is set to rise to almost 40% by 2016, albeit with smaller margins Pharmaceutical companies are prepared to relocate their administration (44%), R D (43%) and sales departments (51%) to emerging …


Raptor Pharmaceutical (RPTP) Stock Slumps, Said to be Exploring Sale #biotechnology #jobs

Posted On Apr 3 2017 by

#raptor pharma # Raptor Pharmaceutical (RPTP) Stock Slumps, Said to be Exploring Sale NEW YORK (TheStreet ) — Shares of Raptor Pharmaceutical Corp. (RPTP ) are dipping by 5.85% to $5.47 on heavy trading volume Thursday afternoon, as the biopharmaceutical company is in talks with investment banks to hire a financial adviser to explore a possible sale, according to sources cited by Reuters after yesterday’s market close. The move may not lead to a sale, the sources added. JMP Securities upgraded the stock to “market outperform” from “market perform” and established a $9 price target following the report. A sale …


URL Pharma may no longer be cash cow in Philadelphia #par #pharma

Posted On Mar 31 2017 by

#url pharma # URL Pharma may no longer be cash cow in Philadelphia By David Sell The Philadelphia Inquirer The future looks dicey for the Philadelphia operations of URL Pharma, a decades-old drug company that succeeded in raising the price of a popular gout medicine by 100 times despite an outcry from sufferers of the painful affliction. The price increase was an expected, but unintended, consequence of a Food and Drug Administration program that began in 2006 that tried to lay scientific foundations under medicines in use for decades or centuries, but whose safety and efficacy has not been tested …


MDS Pharma to be Split, Sold to Ricerca and Private Investment Firm – CenterWatch News

Posted On Mar 26 2017 by

#mds pharma services #